Cargando…

Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma

PURPOSE: Circulating tumor DNA (ctDNA) enables personalized treatment strategies in oncology by providing a noninvasive source of clinical biomarkers. In patients with low ctDNA abundance, tumor-naïve methods are needed to facilitate clinical implementation. Here, using locoregionally confined head...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burgener, Justin M., Zou, Jinfeng, Zhao, Zhen, Zheng, Yangqiao, Shen, Shu Yi, Huang, Shao Hui, Keshavarzi, Sareh, Xu, Wei, Liu, Fei-Fei, Liu, Geoffrey, Waldron, John N., Weinreb, Ilan, Spreafico, Anna, Siu, Lillian L., de Almeida, John R., Goldstein, David P., Hoffman, Michael M., De Carvalho, Daniel D., Bratman, Scott V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2021
Materias:	Precision Medicine and Imaging
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401560/ https://www.ncbi.nlm.nih.gov/pubmed/34158359 http://dx.doi.org/10.1158/1078-0432.CCR-21-0110

Ejemplares similares

HPV Sequencing Facilitates Ultrasensitive Detection of HPV Circulating Tumor DNA
por: Leung, Eric, et al.
Publicado: (2021)

74325 Vast sex-specific differences in transcriptional landscapes of pancreatic neuroendocrine tumors
por: Ivanov, Nikolay A., et al.
Publicado: (2021)

The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA
por: Lee, Jessica K., et al.
Publicado: (2022)

Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
por: Meagher, Nicola S., et al.
Publicado: (2022)

A Case of Metastatic Atypical Neuroendocrine Tumor with ALK Translocation and Diffuse Brain Metastases
por: Wang, Victoria E., et al.
Publicado: (2017)

Designing circulating tumor DNA-based interventional clinical trials in oncology
por: Araujo, Daniel V., et al.
Publicado: (2019)

VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
por: Cheng, Vinton W.T., et al.
Publicado: (2022)

Metastatic Breast Cancer With ESR1 Mutation: Clinical Management Considerations From the Molecular and Precision Medicine (MAP) Tumor Board at Massachusetts General Hospital
por: Bardia, Aditya, et al.
Publicado: (2016)

Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
por: Martin, John D., et al.
Publicado: (2022)

Computer-assisted image analysis of the tumor microenvironment on an oral tongue squamous cell carcinoma tissue microarray
por: Lee, Sangjune Laurence, et al.
Publicado: (2019)

(18)F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition
por: Reeves, Kirsten M., et al.
Publicado: (2022)

Lin28b Promotes Head and Neck Cancer Progression via Modulation of the Insulin-Like Growth Factor Survival Pathway
por: Alajez, Nehad M., et al.
Publicado: (2012)

Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced Leiomyosarcoma
por: Madanat-Harjuoja, Laura M., et al.
Publicado: (2022)

Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non–Small Cell Lung Cancer
por: Pellini, Bruna, et al.
Publicado: (2023)

4228 A latent class analysis of seriously ill adults with multiple chronic conditions receiving palliative care
por: Murali, Komal, et al.
Publicado: (2020)

Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up
por: Lindskrog, Sia V., et al.
Publicado: (2023)

359 Utilization of machine learning approaches on multimodal and ambulatory data to predict individualized symptom course in adults with obsessive-compulsive disorder.
por: Frank, Adam C, et al.
Publicado: (2023)

266 Decoding the role of polyamine metabolism on anti-tumor immunity in head and neck cancer
por: Harbison, Richard Alexander, et al.
Publicado: (2023)

Selinexor for the treatment of recurrent or metastatic salivary gland tumors: Results from the GEMS‐001 clinical trial
por: Hernando‐Calvo, Alberto, et al.
Publicado: (2023)

Detection of an ALK Fusion in Colorectal Carcinoma by Hybrid Capture‐Based Assay of Circulating Tumor DNA
por: Lai, Andrea Z., et al.
Publicado: (2017)

Gallium-68–labeled Peptide PET Quantifies Tumor Exposure of PD-L1 Therapeutics
por: Mishra, Akhilesh, et al.
Publicado: (2023)

Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: Current research, opportunities, and challenges
por: Sanz-Garcia, Enrique, et al.
Publicado: (2022)

81030 Utilizing a synergistic drug combination to target relapsed/refractory FLT3 mutant AML
por: Jones, LaQuita, et al.
Publicado: (2021)

4167 Peri-transplant Lung Microbiome Reveal Oral Bacteria, Pepsin And Inflammatory Markers Co-associate With Primary Graft Dysfunction, Implicating Aspiration As A Potential Contributor
por: McGinniss, John Evan, et al.
Publicado: (2020)

Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)
por: Tovey, Holly, et al.
Publicado: (2023)

Diagnostic Performance of a Tumor Marker Gene Test to Personalize Serum CA19–9 Reference Ranges
por: Dbouk, Mohamad, et al.
Publicado: (2023)

77680 Nasal Nitric Oxide Levels as a Diagnostic Tool for Primary Ciliary Dyskinesia in Puerto Rico
por: De Jesus Rojas, Wilfredo, et al.
Publicado: (2021)

Biological Misinterpretation of Transcriptional Signatures in Tumor Samples Can Unknowingly Undermine Mechanistic Understanding and Faithful Alignment with Preclinical Data
por: Fisher, Natalie C., et al.
Publicado: (2022)

Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response
por: Zhou, Qing, et al.
Publicado: (2022)

Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program
por: Bychkovsky, Brittany L., et al.
Publicado: (2022)

Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer
por: Williams, Christopher J.M., et al.
Publicado: (2023)

Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer
por: Damrauer, Jeffrey S., et al.
Publicado: (2021)

DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy
por: Tawk, Bouchra, et al.
Publicado: (2023)

Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences
por: Henriksen, Tenna Vesterman, et al.
Publicado: (2022)

342 The Implications of High Expression of VISTA, a Negative Check Point Regulator, on Prognosis Across Malignant Solid Tumors: a Systematic Review and Meta-Analysis
por: Martin, Alexander S, et al.
Publicado: (2023)

Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
por: Lheureux, Stephanie, et al.
Publicado: (2023)

Urinary proteomics combined with home blood pressure telemonitoring for health care reform trial—First progress report
por: Chori, Babangida S., et al.
Publicado: (2023)

Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study)
por: Oliva, Marc, et al.
Publicado: (2021)

Histopathological Characteristics of Gastrointestinal Stromal Tumors in a Cohort of Vietnamese Patients
por: Nguyen Cuong, Pham, et al.
Publicado: (2020)

DNA Polymerase ɛ Deficiency Leading to an Ultramutator Phenotype: A Novel Clinically Relevant Entity
por: Castellucci, Enrico, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g86d09ss5ugp0rg7de2bd3asso